Q1: 2026-04-28 Earnings Summary
EPS of $0.48 misses by $0.02
|
Revenue of
$266.86M
(16.85% Y/Y)
beats by $157.22K
Omega Healthcare Investors, Inc. (OHI) Q1 2026 Earnings Call April 29, 2026 10:00 AM EDT
Company Participants
Michele Reber - Senior Director of Asset Management
C. Pickett - CEO & Director
Matthew Gourmand - President
Vikas Gupta - Chief Investment Officer
Robert O. Stephenson - CFO, Treasurer & Assistant Secretary
Megan Krull - Senior Vice President of Data, Intelligence & Government Relations
Conference Call Participants
Richard Anderson - Cantor Fitzgerald & Co., Research Division
Michael Goldsmith - UBS Investment Bank, Research Division
Julien Blouin - Goldman Sachs Group, Inc., Research Division
Omotayo Okusanya - Deutsche Bank AG, Research Division
William John Kilichowski - Wells Fargo Securities, LLC, Research Division
Elmer Chang - Scotiabank Global Banking and Markets, Research Division
Michael Carroll - RBC Capital Markets, Research Division
Juan Sanabria - BMO Capital Markets Equity Research
Wesley Golladay - Robert W. Baird & Co. Incorporated, Research Division
Vikram Malhotra - Mizuho Securities USA LLC, Research Division
Michael Stroyeck - Green Street Advisors, LLC, Research Division
Farrell Granath - BofA Securities, Research Division
Presentation
Operator
Ladies and gentlemen, thank you for standing by. Welcome to Omega Healthcare Investors Inc. First Quarter Earnings Conference Call. [Operator Instructions] I will now turn the conference over to Michele Reber. You may begin.
Michele Reber
Senior Director of Asset Management
Thank you, and good morning. With me today is Omega's CEO, Taylor Pickett; President, Matthew Gourmand; CFO, Bob Stephenson; CIO, Vikas Gupta; and Megan Krull, Senior Vice President, Data Intelligence and Government Relations.
Comments made during this conference call that are not historical facts may be forward-looking statements, such as statements regarding our financial projections, potential transactions, operator prospects and outlook generally. Factors that could cause actual results to differ materially from those in the forward-looking statements are detailed in the company's filings with the SEC.
During the call today, we will refer to some non-GAAP financial measures, such as NAREIT FFO, adjusted
此内容由惯性聚合(RSS阅读器)自动聚合整理，仅供阅读参考。 原文来自 — 版权归原作者所有。